Literature DB >> 21159816

Repression of the miR-143/145 cluster by oncogenic Ras initiates a tumor-promoting feed-forward pathway.

Oliver A Kent1, Raghu R Chivukula, Michael Mullendore, Erik A Wentzel, Georg Feldmann, Kwang H Lee, Shu Liu, Steven D Leach, Anirban Maitra, Joshua T Mendell.   

Abstract

Although activating mutations in RAS oncogenes are known to result in aberrant signaling through multiple pathways, the role of microRNAs (miRNAs) in the Ras oncogenic program remains poorly characterized. Here we demonstrate that Ras activation leads to repression of the miR-143/145 cluster in cells of human, murine, and zebrafish origin. Loss of miR-143/145 expression is observed frequently in KRAS mutant pancreatic cancers, and restoration of these miRNAs abrogates tumorigenesis. miR-143/145 down-regulation requires the Ras-responsive element-binding protein (RREB1), which represses the miR-143/145 promoter. Additionally, KRAS and RREB1 are targets of miR-143/miR-145, revealing a feed-forward mechanism that potentiates Ras signaling.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21159816      PMCID: PMC3003192          DOI: 10.1101/gad.1950610

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  40 in total

1.  An in vivo platform for translational drug development in pancreatic cancer.

Authors:  Belen Rubio-Viqueira; Antonio Jimeno; George Cusatis; Xianfeng Zhang; Christine Iacobuzio-Donahue; Collins Karikari; Chanjusn Shi; Kathleen Danenberg; Peter V Danenberg; Hidekazu Kuramochi; Koji Tanaka; Sharat Singh; Hossein Salimi-Moosavi; Nadia Bouraoud; Maria L Amador; Soner Altiok; Piotr Kulesza; Charles Yeo; Wells Messersmith; James Eshleman; Ralph H Hruban; Anirban Maitra; Manuel Hidalgo
Journal:  Clin Cancer Res       Date:  2006-08-01       Impact factor: 12.531

2.  Identifying allelic loss and homozygous deletions in pancreatic cancer without matched normals using high-density single-nucleotide polymorphism arrays.

Authors:  Eric S Calhoun; Tomas Hucl; Eike Gallmeier; Kristen M West; Dan E Arking; Anirban Maitra; Christine A Iacobuzio-Donahue; Aravinda Chakravarti; Ralph H Hruban; Scott E Kern
Journal:  Cancer Res       Date:  2006-08-15       Impact factor: 12.701

3.  A human Raf-responsive zinc-finger protein that binds to divergent sequences.

Authors:  L Zhang; J Zhao; H J Edenberg
Journal:  Nucleic Acids Res       Date:  1999-07-15       Impact factor: 16.971

4.  The let-7 microRNA reduces tumor growth in mouse models of lung cancer.

Authors:  Aurora Esquela-Kerscher; Phong Trang; Jason F Wiggins; Lubna Patrawala; Angie Cheng; Lance Ford; Joanne B Weidhaas; David Brown; Andreas G Bader; Frank J Slack
Journal:  Cell Cycle       Date:  2008-03-03       Impact factor: 4.534

Review 5.  Pancreatic cancer.

Authors:  Anirban Maitra; Ralph H Hruban
Journal:  Annu Rev Pathol       Date:  2008       Impact factor: 23.472

6.  Oncogenic KRAS induces progenitor cell expansion and malignant transformation in zebrafish exocrine pancreas.

Authors:  Seung Woo Park; Jon M Davison; Jerry Rhee; Ralph H Hruban; Anirban Maitra; Steven D Leach
Journal:  Gastroenterology       Date:  2008-03-05       Impact factor: 22.682

7.  Hedgehog inhibition prolongs survival in a genetically engineered mouse model of pancreatic cancer.

Authors:  G Feldmann; N Habbe; S Dhara; S Bisht; H Alvarez; V Fendrich; R Beaty; M Mullendore; C Karikari; N Bardeesy; M M Ouellette; W Yu; A Maitra
Journal:  Gut       Date:  2008-05-30       Impact factor: 23.059

8.  Functional integration of microRNAs into oncogenic and tumor suppressor pathways.

Authors:  Craig D Lotterman; Oliver A Kent; Joshua T Mendell
Journal:  Cell Cycle       Date:  2008-08-17       Impact factor: 4.534

9.  Raf kinase inhibitory protein suppresses a metastasis signalling cascade involving LIN28 and let-7.

Authors:  Surabhi Dangi-Garimella; Jieun Yun; Eva M Eves; Martin Newman; Stefan J Erkeland; Scott M Hammond; Andy J Minn; Marsha Rich Rosner
Journal:  EMBO J       Date:  2009-01-15       Impact factor: 11.598

10.  Large-scale mutagenesis in p19(ARF)- and p53-deficient mice identifies cancer genes and their collaborative networks.

Authors:  Anthony G Uren; Jaap Kool; Konstantin Matentzoglu; Jeroen de Ridder; Jenny Mattison; Miranda van Uitert; Wendy Lagcher; Daoud Sie; Ellen Tanger; Tony Cox; Marcel Reinders; Tim J Hubbard; Jane Rogers; Jos Jonkers; Lodewyk Wessels; David J Adams; Maarten van Lohuizen; Anton Berns
Journal:  Cell       Date:  2008-05-16       Impact factor: 41.582

View more
  159 in total

Review 1.  Novel therapeutic targets for pancreatic cancer.

Authors:  Shing-Chun Tang; Yang-Chao Chen
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

2.  MiR-145 inhibits tumor angiogenesis and growth by N-RAS and VEGF.

Authors:  Chao Zou; Qing Xu; Feng Mao; Dan Li; Chuanxiu Bian; Ling-Zhi Liu; Yue Jiang; Xiaona Chen; Yanting Qi; Xiaolong Zhang; Xuejing Wang; Qiang Sun; Hsiang-Fu Kung; Marie C Lin; Andreas Dress; Fiona Wardle; Bing-Hua Jiang; Lihui Lai
Journal:  Cell Cycle       Date:  2012-06-01       Impact factor: 4.534

3.  An essential mesenchymal function for miR-143/145 in intestinal epithelial regeneration.

Authors:  Raghu R Chivukula; Guanglu Shi; Asha Acharya; Eric W Mills; Lauren R Zeitels; Joselin L Anandam; Abier A Abdelnaby; Glen C Balch; John C Mansour; Adam C Yopp; Anirban Maitra; Joshua T Mendell
Journal:  Cell       Date:  2014-05-22       Impact factor: 41.582

Review 4.  Aberrantly expressed microRNAs in bladder cancer and renal cell carcinoma.

Authors:  Akira Kurozumi; Yusuke Goto; Atsushi Okato; Tomohiko Ichikawa; Naohiko Seki
Journal:  J Hum Genet       Date:  2016-06-30       Impact factor: 3.172

5.  EGFR signals downregulate tumor suppressors miR-143 and miR-145 in Western diet-promoted murine colon cancer: role of G1 regulators.

Authors:  Hongyan Zhu; Urszula Dougherty; Victoria Robinson; Reba Mustafi; Joel Pekow; Sonia Kupfer; Yan Chun Li; John Hart; Kathleen Goss; Alessandro Fichera; Loren Joseph; Marc Bissonnette
Journal:  Mol Cancer Res       Date:  2011-06-08       Impact factor: 5.852

Review 6.  MicroRNAs in pancreatic malignancy: progress and promises.

Authors:  Sanjeev K Srivastava; Sumit Arora; Seema Singh; Arun Bhardwaj; Courey Averett; Ajay P Singh
Journal:  Cancer Lett       Date:  2014-02-20       Impact factor: 8.679

7.  The tumor-suppressive microRNA-143/145 cluster inhibits cell migration and invasion by targeting GOLM1 in prostate cancer.

Authors:  Satoko Kojima; Hideki Enokida; Hirofumi Yoshino; Toshihiko Itesako; Takeshi Chiyomaru; Takashi Kinoshita; Miki Fuse; Rika Nishikawa; Yusuke Goto; Yukio Naya; Masayuki Nakagawa; Naohiko Seki
Journal:  J Hum Genet       Date:  2013-11-28       Impact factor: 3.172

Review 8.  Emergence of zebrafish models in oncology for validating novel anticancer drug targets and nanomaterials.

Authors:  Murielle Mimeault; Surinder K Batra
Journal:  Drug Discov Today       Date:  2012-08-10       Impact factor: 7.851

9.  Signature microRNAs in human cornea limbal epithelium.

Authors:  Yufei Teng; Hoi Kin Wong; Vishal Jhanji; Jian Huan Chen; Alvin Lerrmann Young; Mingzhi Zhang; Kwong Wai Choy; Jodhbir Singh Mehta; Chi Pui Pang; Gary Hin-Fai Yam
Journal:  Funct Integr Genomics       Date:  2014-12-07       Impact factor: 3.410

10.  Insights into the Role of microRNAs in Pancreatic Cancer Pathogenesis: Potential for Diagnosis, Prognosis, and Therapy.

Authors:  Mohammad Aslam Khan; Haseeb Zubair; Sanjeev Kumar Srivastava; Seema Singh; Ajay Pratap Singh
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.